Anti CD20 Antibody (Rituximab) Therapy Leads to High Molecular Remission Rate with Favourable Outcome in Patients with Non-Hodgkin's Lymphoma

Abstract

minomal residual disease, polymerase chain reaction, autologous stem cell transplantation